NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case–control study

OBJECTIVES: Non-steroidal anti-inflammatory drugs (NSAIDs), proton pump inhibitors (PPIs), low-dose aspirin and statins may decrease the risk of oesophageal adenocarcinoma (OAC) among patients with Barrett's oesophagus (BO). However, previous studies did not adequately address bias and confound...

Descripción completa

Detalles Bibliográficos
Autores principales: Masclee, Gwen M C, Coloma, Preciosa M, Spaander, Manon C W, Kuipers, Ernst J, Sturkenboom, Miriam C J M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Gastroenterology and Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316430/
https://www.ncbi.nlm.nih.gov/pubmed/25633286
http://dx.doi.org/10.1136/bmjopen-2014-006640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316430/
https://www.ncbi.nlm.nih.gov/pubmed/25633286
http://dx.doi.org/10.1136/bmjopen-2014-006640

Ejemplares similares